BACKGROUND: Diagnosis of Congenital Adrenal Hyperplasia (CAH) is based on the quantification of 17-hydroxyprogesterone (17-OHP), usually by immunoassay. During the neonatal period the specificity of screening for CAH by blood spot 17-OHP immunoassay is low. High false-positive rates result in a relatively high demand for a second-tier serum confirmation test. A robust, specific and selective method for measurement of cortisol, 21-deoxycortisol, 11-deoxycortisol, 4-androstene-3,17-dione (A4) and 17-OHP in serum has been developed. The method involves a simple extraction procedure and a fast analysis using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC/MS/MS). METHODS: The steroids were extracted from 50microl of serum using methyl-tert-butyl-ether. Analysis was performed on a UPLC tandem quadrupole mass spectrometer system in positive mode electrospray ionization and multiple reaction monitoring acquisition. RESULTS: The assay was linear over each analyte concentration range with all correlation coefficients (r(2))>0.996. Inter- and intra-day CVs were <or=10% across the analytical range. In addition simultaneous measurement of the full range of steroids on the pathway to cortisol allows confirmation of the affected steroidogenic enzyme. CONCLUSIONS: A second-tier test for the confirmation of CAH has been developed. The method allows for detection and quantification of 5 steroids related to CAH over the range of the clinical assay with good linearity, sensitivity and precision. Copyright 2009 Elsevier B.V. All rights reserved.
BACKGROUND: Diagnosis of Congenital Adrenal Hyperplasia (CAH) is based on the quantification of 17-hydroxyprogesterone (17-OHP), usually by immunoassay. During the neonatal period the specificity of screening for CAH by blood spot 17-OHP immunoassay is low. High false-positive rates result in a relatively high demand for a second-tier serum confirmation test. A robust, specific and selective method for measurement of cortisol, 21-deoxycortisol, 11-deoxycortisol, 4-androstene-3,17-dione (A4) and 17-OHP in serum has been developed. The method involves a simple extraction procedure and a fast analysis using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC/MS/MS). METHODS: The steroids were extracted from 50microl of serum using methyl-tert-butyl-ether. Analysis was performed on a UPLC tandem quadrupole mass spectrometer system in positive mode electrospray ionization and multiple reaction monitoring acquisition. RESULTS: The assay was linear over each analyte concentration range with all correlation coefficients (r(2))>0.996. Inter- and intra-day CVs were <or=10% across the analytical range. In addition simultaneous measurement of the full range of steroids on the pathway to cortisol allows confirmation of the affected steroidogenic enzyme. CONCLUSIONS: A second-tier test for the confirmation of CAH has been developed. The method allows for detection and quantification of 5 steroids related to CAH over the range of the clinical assay with good linearity, sensitivity and precision. Copyright 2009 Elsevier B.V. All rights reserved.
Authors: Alexander J Frey; Qingqing Wang; Christine Busch; Daniel Feldman; Lisa Bottalico; Clementina A Mesaros; Ian A Blair; Anil Vachani; Nathaniel W Snyder Journal: Steroids Date: 2016-10-13 Impact factor: 2.668
Authors: Maria Alessandra Saltarelli; Rossella Ferrante; Francesca Di Marcello; Daniela David; Silvia Valentinuzzi; Lucrezia Pilenzi; Luca Federici; Claudia Rossi; Liborio Stuppia; Stefano Tumini Journal: Int J Environ Res Public Health Date: 2022-06-04 Impact factor: 4.614
Authors: Carolyn J Broccardo; Kevin L Schauer; Wendy M Kohrt; Robert S Schwartz; James P Murphy; Jessica E Prenni Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2013-07-04 Impact factor: 3.205
Authors: Wiebke Arlt; Michael Biehl; Angela E Taylor; Stefanie Hahner; Rossella Libé; Beverly A Hughes; Petra Schneider; David J Smith; Han Stiekema; Nils Krone; Emilio Porfiri; Giuseppe Opocher; Jerôme Bertherat; Franco Mantero; Bruno Allolio; Massimo Terzolo; Peter Nightingale; Cedric H L Shackleton; Xavier Bertagna; Martin Fassnacht; Paul M Stewart Journal: J Clin Endocrinol Metab Date: 2011-09-14 Impact factor: 5.958
Authors: Borahm Kim; Mi Na Lee; Hyung Doo Park; Jong Won Kim; Yun Sil Chang; Won Soon Park; Soo Youn Lee Journal: Ann Lab Med Date: 2015-11 Impact factor: 3.464